{"nctId":"NCT00545584","briefTitle":"Addition Of Januvia (Sitagliptin) Improves Glycemic Control In Patients Inadequately Controlled By Metformin (MK0431-078)","startDateStruct":{"date":"2007-04-01","type":"ACTUAL"},"conditions":["Diabetes Mellitus, Non-Insulin-Dependent"],"count":1512,"armGroups":[{"label":"Sitagliptin with Standard of Care","type":"EXPERIMENTAL","interventionNames":["Drug: sitagliptin phosphate"]},{"label":"Sitagliptin with Diet Advice","type":"EXPERIMENTAL","interventionNames":["Drug: sitagliptin phosphate","Behavioral: Comparator: Diet"]},{"label":"Sitagliptin with Diet and Physical Activity Advice","type":"EXPERIMENTAL","interventionNames":["Drug: sitagliptin phosphate","Behavioral: Comparator: Diet","Behavioral: Comparator: Physical Activity"]}],"interventions":[{"name":"sitagliptin phosphate","otherNames":[]},{"name":"Comparator: Diet","otherNames":[]},{"name":"Comparator: Physical Activity","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Man or woman aged \\>/= 18 years,with T2DM and treated with the maximal tolerated dose of metformin, with documented or high likely inadequate control of diabetes (HbA1c 6.5-9%)\n\nExclusion Criteria:\n\n* Daily insulin treatment or one insulin dose or more within the last 8 weeks or expected insulin treatment within the next 3 months.\n* Hypoglycemia unawareness or recurrent major hypoglycemia or history of acidoketosis\n* Known hypersensitivity or contraindication to metformin","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Hemoglobin A1c Measurement","description":"Hemoglobin A1c (HbA1c) is a measure of glycated hemoglobin in the blood. HbA1c greater than 6.5% was considered inadequately controlled.","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"7.37","spread":"0.61"},{"groupId":"OG001","value":"7.50","spread":"0.66"},{"groupId":"OG002","value":"7.49","spread":"0.60"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"7.33","spread":"1.09"},{"groupId":"OG001","value":"7.42","spread":"1.15"},{"groupId":"OG002","value":"7.40","spread":"1.07"}]}]}]},{"type":"SECONDARY","title":"Fasting Plasma Glucose (FPG) Measurement","description":"Generally FPG values of \\~5.0-7.2 mmol/L would be considered goal (American Diabetes Association).","paramType":"MEAN","dispersionType":"Standard Deviation","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"8.87","spread":"1.98"},{"groupId":"OG001","value":"9.00","spread":"2.03"},{"groupId":"OG002","value":"8.91","spread":"1.87"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"8.21","spread":"2.07"},{"groupId":"OG001","value":"8.32","spread":"2.08"},{"groupId":"OG002","value":"8.47","spread":"2.17"}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":8,"n":412},"commonTop":[]}}}